(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 7.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 57.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Alector's revenue in 2025 is $88,339,000.On average, 3 Wall Street analysts forecast ALEC's revenue for 2025 to be $1,217,009,935, with the lowest ALEC revenue forecast at $966,928,442, and the highest ALEC revenue forecast at $1,417,295,112. On average, 3 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,228,909,054, with the lowest ALEC revenue forecast at $420,968,846, and the highest ALEC revenue forecast at $1,999,852,000.
In 2027, ALEC is forecast to generate $12,744,756,818 in revenue, with the lowest revenue forecast at $4,369,676,620 and the highest revenue forecast at $23,058,293,560.